Tiefenbacher Group renovation

Tiefenbacher Group renovation of headquarters

Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.

Tiefenbacher Group is happy to present some of the results of the remodelling and to bring even more changes to life.

In accordance with the modern design of the building, we are creating an innovative and state-of-the-art workspace. So it reflects our culture of entrepreneurship, professionalism and openness. The open-plan concept encourages creativity, collaboration and teamwork among our employees. Overall, the interior is airy, transparent and flooded with light. The modernisation also allowed us to integrate new branding elements into the workspace. We are convinced that the new premises directly on the banks of the river Elbe offer a great working environment. Furthermore it also promotes the growth and well-being of our employees.

The full modernisation of our headquarters is expected to be completed later this year.

Taking responsibility is part of the Tiefenbacher Group’s corporate culture. We want to create a positive working environment by improving our working environment to provide our team with the perfect place to work. Our culture of caring is essential to achieving our goal of making a difference in the daily lives of people and the planet around the world.

We will continue to improve our workplace to foster the best environment for our team to realise their full potential. We will keep you updated on the progress and look forward to welcoming you to our new offices soon!

Tiefenbacher Group renovation

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Pharmaceuticals wishes a Happy Chinese New Year!

Tiefenbacher Pharmaceuticals wishes a Happy Chinese New Year!

The Chinese New Year is almost here.

On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional food, fireworks and other festivities. It is one of the most important public holidays. Incidentally not only in China, but also in many other Asian countries that traditionally follow the lunar calendar. In Vietnam, Korea and Mongolia, for example, the new year is also celebrated on 10 February. Generally the Chinese New Year begins on the first day of the Chinese calendar and ends on the 15th day with the Yuanxiao Festival, the traditional lantern festival.

We at Tiefenbacher Pharmaceuticals greatly appreciate the diversity of our colleagues and look forward to celebrating their local traditions together. In the culture of our Chinese partners and colleagues, each year is associated with a particular animal of the Chinese zodiac. This year is the year of the dragon.

Tiefenbacher Pharmaceuticals is wishing you and your loved ones four seasons of peace and a flourishing year of the dragon.

Tiefenbacher Pharmaceuticals wishes a Happy Chinese New Year!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Pharmaceuticals DKMS

Tiefenbacher Pharmaceuticals together against blood cancer

Tiefenbacher Pharmaceuticals and DKMS together against blood cancer!

First of all we are pleased to inform you that we have initiated a DKMS registration event during the last week in our headquartes in Hamburg to look for potential donors who are willing to help people with blood cancer or other blood disorders with their blood stem cells. Accordingly to DKMS research every year, nearly one million people are diagnosed with blood cancer. For many of them a stem cell transplant is the only chance of survival. Only around a third of them find a suitable stem cell donor within their own family.

DKMS Group is an international nonprofit organization dedicated to the fight against blood cancer and blood disorders by creating awareness, recruiting bone marrow donors to provide a second chance at life, raising funds to match donor registrations costs, and supporting the improvement of blood cancer therapies by their own research. Additionally we are happy to further support this important organization by a monetary donation.

All in all: Thanks a lot to all colleagues who have registered! We hope that we can also inspire people outside our company to get involved Swabbing is easy and painless! Let´s save lives together and register: Stammzellspende: Registriere dich hier! | DKMS Deutschland. People from any other country find their local registry here: Become a donor | WMDA

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com

Tiefenbacher Pharmaceuticals DKMS

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Pharmaceuticals diversity

Tiefenbacher Pharmaceuticals speaks out against racism and supports diversity

TIEFENBACHER PHARMACEUTICALS speaks out against racism and supports diversity - as a healthcare company, we are committed to stopping racism and discrimination, wherever we can

Tiefenbacher embraces its responsibility to be a force for good – both through our pharmaceuticals and our broader action to address inequities and to create environment where all people are valued and respected. Diversity and inclusion are fundamental to the way we operate an to our purpose to improve people’s lives.  In light of recent events, we would like to express our full support for the demonstrations against racism and discrimination across Germany and welcome the fact that so many people took to the streets at the weekend.

Diversity is an integral part at Tiefenbacher Group. We are proud to have a team of 26 different nationalities and believe that a diverse team brings a wealth of perspectives, experiences and ideas that drive innovation and success in pioneering healthcare.

We recognize the unique strengths that each member of our team brings to the table, and we understand that fostering an inclusive environment is not only the right thing to do but also a key driver of our collective success.

These demonstrations are a powerful reminder that we as a society must continue to strive for equality, justice and a world where every person is treated with dignity and respect, regardless of their background. We want Germany to remain a country with a diverse society and to remain tolerant, divers, and welcoming.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).  

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com

Tiefenbacher Pharmaceuticals diversity
Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email atinfo@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Featured Video Play Icon

AET Laboratories 20th anniversary celebration

Last year, we not only celebrated Tiefenbacher Group´s  60th anniversary in Hamburg, but also the 20th anniversary of AET Laboratories – our development and manufacturing site in Hyderabad, India.

AET Laboratories 20th anniversary celebration was a tremendous success!

Before the end-of-year celebrations, some games like cricket, badminton, lemon spoon, tennis kite etc. were conducted for all employees to participate in.
The management also distributed sportswear and shoes to around 80 students of the school sponsored by Tiefenbacher Group. As a grand finale, AET Labs’ 20th birthday was celebrated with cultural activities such as dancing, singing, skits, and distribution of prizes to the winners of various sports.

Thank you to everyone who made this wonderful event possible. You made this celebration very special and created a unique atmosphere in which our so-called “Tifi spirit” came alive.

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

Tiefenbacher Pharmaceuticals wishes you a happy new year!

TIEFENBACHER PHARMACEUTICALS, a part of TIEFENBACHER GROUP: As 2023 draws to a close, we would like to share some of the year's highlights with you.

This year we not only had our 60th anniversary to celebrate, but also many other great events:

In addition to several international generic launches we have successfully prepared the launch of the antihistamine Bilastine for a market entry as over-the-counter medicine in Germany. Furthermore we presented our innovative healthcare brand OYSTA in collaboration with OnDosis and inaugurated our new development block “Alfred” for highly potent drugs in Hyderabad, India.

Additionally we defined our sustainability goals for the future and started to implement them by installing solar panels at our site in Cyprus, replanting trees on building land in India, and setting up e-bike stations at our headquarters. Our social projects have not been neglected either, we have built a school in India, our employees have spent their social day in charitable institutions in Hamburg and our team has collected donations for charity.

This year we have been to numerous fairs and events to meet you in person and tell you about our latest product portfolio and how we make pharmaceuticals more affordable, more available, and better than before!

All in all we hope the year 2024 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the world!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in Canada

We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of the anticoagulant Rivaroxaban in Canada.

Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Rivaroxaban is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. It makes blood flow through veins more easily by stopping a clotting factor called factor Xa from working. Rivaroxaban is also used to reduces the risk of stroke and systemic embolism with nonvalvular atrial fibrillation. The tablets are marketed in the strengths 2.5mg (for the very first time), 10mg, 15mg, and 20mg by our cooperation partner.

The product has been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India. Also it has already been launched in several European and international markets before. Overall, Tiefenbacher country scope covers about 70 countries around the world. Furthermore, the successful launch of this anticoagulant is a testament to the hard work and dedication of the team.

Finally, we are particularly excited about the positive impact of the launch of rivaroxaban. Look forward to further market entries with high-quality medicines – with a patient-centred approach for better healthcare.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Featured Video Play Icon

Tiefenbacher Pharmaceuticals at CPhI Barcelona 2023

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, at CPHI Barcelona 2023

We are pleased to say that we have had three very successful days full of inspiring meetings CPHI Barcelona 2023. A big thanks to all who visited us in Barcelona. It was wonderful to meet many familiar and new faces and we are already looking forward to seeing you again next year in Milan!

Thank you to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for making this expo so special.

The Tiefenbacher Group participated in the CPhI, the world’s leading event for the pharmaceutical industry, from October 24 to 26 in Barcelona! Where visitors could explore the new booth of Tiefenbacher and discover our latest product portfolio and innovations in the field of raw materials, finished dosage forms, and medical devices! This was the opportunity to get in touch with many of our experts to discuss new business opportunities and ideas for making pharmaceuticals more affordable, more available, and better than before!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

60 years of pioneering healthcare at Tiefenbacher Group! 

Tiefenbacher Pharamaceuticals – a part of Tiefenfacher Group:
60 years of Pioneering Healthcare

Tiefenbacher Group says “Thank you” to our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus) for sharing their short 60-year anniversary greetings in their respective national languages with you.

We are proud to have a team of 26 different nationalities and believe that a diverse team brings a wealth of perspectives, experiences and ideas that drive innovation and success in pioneering healthcare. It is unbelievable to have so many talented and outstanding employees in our group! With the curiosity and commitment of our employees we will continue to make medicines better affordable, better available, and better than before!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

Tiefenbacher Group 60 years anniversary celebration!

Tiefenbacher Pharamaceuticals – a part of Tiefenfacher Group:
60 years anniversary celebrations

We are very happy to announce that Tiefenbacher Group celebrates its 60th anniversary this year!

60 years ago, our founder and pioneer Alfred E. Tiefenbacher started our pharmaceutical business in Germany. 30 years later, we became an European company and today, 60 years later, we are a globally operating healthcare company which improves patients´ lives around the world. Since our founding, we have always been driven by our purpose to make pharmaceuticals better affordable, better available, and better than before!

Watch our three managing directors from our headquarters in Hamburg Dr. Kristian Ruepp, Oliver Schrader, and Frank Tettinger in our short video answering 3 central questions about Tiefenbacher Group!

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com